Medglobe Therapeutics Limited - Company Profile

It is a pharma public limited company based in Delhi, Delhi, India, established in 2006.
2006 Delhi, Delhi, India Active
Last Updated:
Access Report
About Medglobe Therapeutics Limited

Medglobe Therapeutics Limited, a active public limited company, was established on 24 April 2006 in Delhi, Delhi, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24239DL2006PLC368703. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹5.00 Cr and a paid-up capital of ₹2.85 Cr.

Formerly known as Opus Life Sciences Limited. It upholds a compliant status. Employing 57 professional, Its leadership includes Anuj Kumar Garawal (Director), Varun Singh (Director), Amit Singh (Director). Past directors included Pramod Kumar Singh, Kande Veera Pratap, Kishore Kumar Musthyala. It holds ₹4.00 Cr open charges and ₹6.60 Cr settled loans. Its latest AGM occurred on 29 September 2025, with the balance sheet filed on 31 March 2025. It is based at 5/9 A, Roop Nagar, Delhi, Delhi, 110007.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24239DL2006PLC368703

  • Registration Number

    368703

  • Incorporation Date

    24 April 2006

  • Authorized Capital

    ₹5.00 Cr

  • Paid-Up Capital

    ₹2.85 Cr

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 5.00 Cr
  • Paid Up Capital ₹ 2.85 Cr
  • Company Age 19 Year, 10 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 4.00 Cr
  • Satisfied Charges ₹ 6.60 Cr
  • Revenue Growth **** 72.79%
  • Profit Growth **** 24.58%
  • Ebitda **** 42.85%
  • Net Worth 68.15%
  • Total Assets **** 33.28%
Company report

Medglobe Therapeutics Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Medglobe Therapeutics Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Medglobe Therapeutics Limited?
Current Directors
Name Designation Appointment Date Status
Anuj Kumar Garawal Director 03 Jan 2019 Current
Varun Singh Director 05 Mar 2019 Current
Amit Singh Director 03 Jan 2019 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 05 Mar 2019 Past
Pramod Abcsdd Director 17 May 2013 Past
Pramod Abcsdd Director 12 Aug 2013 Past
Pramod Abcsdd Additional Director 30 Sep 2019 Past
Pramod Abcsdd Director 05 Mar 2019 Past
Pramod Abcsdd Director 17 May 2013 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Medglobe Therapeutics.

Medglobe Therapeutics Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 72.79% increase. The company also saw a substantial improvement in profitability, with a 24.58% increase in profit. The company's net worth Soared by an impressive increase of 68.15%.

Medglobe Therapeutics revenue growth over time
Medglobe Therapeutics profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 72.79%
*******
*******
*******
*******
Revenue from Operations
*******
 73.01%
*******
*******
*******
*******
Total Assets
*******
 33.28%
*******
*******
*******
*******
Profit or Loss
*******
 24.58%
*******
*******
*******
*******
Net Worth
*******
 68.15%
*******
*******
*******
*******
EBITDA
*******
 42.85%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Medglobe Therapeutics?

In 2023, Medglobe Therapeutics had a promoter holding of 63.01% and a public holding of 36.99%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹40,000,000.00

Satisfied Charges

₹66,000,000.00

Charges Breakdown by Lending Institutions
  • Others : 4.00 Cr
Latest Charge Details
Date Lender Amount Status
25 Nov 2025 Others ₹3.00 Cr Open
25 Nov 2025 Others ₹1.00 Cr Open
04 Jun 2024 Others ₹4.10 Cr Satisfied
01 Sep 2006 Punjab National Bank ₹2.50 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Medglobe Therapeutics?

Medglobe Therapeutics has a workforce of 57 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Medglobe Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medglobe Therapeutics's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Medglobe Therapeutics
Recent Activity within the Organization
  • Charges

    Progress on A charge registered on 04 Jun 2024 via Charge ID 100952782 with Others was fully satisfied on 14 Jan 2026. was documented.

  • Charges

    The activity A charge with Others amounted to Rs. 3.00 Cr with Charge ID 101215257 was registered on 25 Nov 2025. was completed.

  • Charges

    Progress on A charge with Others amounted to Rs. 1.00 Cr with Charge ID 101215264 was registered on 25 Nov 2025. was documented.

  • Annual General Meeting

    Progress on Medglobe Therapeutics Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records. was documented.

  • Balance Sheet

    Progress on Medglobe Therapeutics Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was documented.

  • Charges

    A charge with Others of Rs. 4.10 Cr registered on 04 Jun 2024 with Charge ID 100952782 was modified on 24 Aug 2024. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Medglobe Therapeutics Limited?

The CIN of Medglobe Therapeutics Limited is U24239DL2006PLC368703.

Where is Medglobe Therapeutics Limited headquartered?

Medglobe Therapeutics Limited is headquartered at 5/9 A, Roop Nagar, Delhi, Delhi, 110007.

When was Medglobe Therapeutics Limited incorporated?

Medglobe Therapeutics Limited was incorporated on 24 April 2006.

Who are the current directors of Medglobe Therapeutics Limited?

The current directors of Medglobe Therapeutics Limited are

What is the primary industry of Medglobe Therapeutics Limited?

The primary industry of Medglobe Therapeutics Limited is Trade.

Is Medglobe Therapeutics Limited a listed company?

Medglobe Therapeutics Limited is unlisted.

What is the capital structure of Medglobe Therapeutics Limited?

The authorized capital of Medglobe Therapeutics Limited is ₹5.00 Cr, and the paid-up capital is ₹2.85 Cr.

What is the compliance status of Medglobe Therapeutics Limited?

The compliance status of Medglobe Therapeutics Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available